Atlas Trials

Efficacy, Safety, and Pharmacokinetics Study of CJM112 in Hidradenitis Suppurativa Patients

Clinical trial NCT02421172 · COMPLETED

Trial details

NCT number
NCT02421172
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hidradenitis Suppurativa (Acne Inversa)
Start date
2015-04-13
Primary completion
2016-11-23
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.